Latest Asx Limited News

ASX Limited announces that CEO Helen Lofthouse will step down in May 2026, coinciding with the imminent go-live of the CHESS project’s first phase. The Board initiates a global search for new leadership to guide the next stage of transformation.

ASX Limited has updated its FY26 expense growth guidance upwards, reflecting increased investments in risk management and technology modernisation alongside ASIC Inquiry-related costs, while reporting strong unaudited 1H26 revenue growth.

Next Science Limited has applied for voluntary delisting from the ASX following the sale of nearly all its assets to OSARTIS GmbH. The company proposes a capital return to shareholders and intends to commence winding up after delisting.

Minbos Resources has obtained a crucial ASX waiver allowing it to issue shares under its Share Purchase Plan without the usual shareholder approval, aligning pricing with its recent Placement and aiming to maintain fairness among investors.

Following a critical ASIC Inquiry Interim Report, ASX has pledged a strategic reset including a $150 million capital charge and enhanced board independence to restore market confidence.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

ASX Limited reaffirms its FY26 expense growth guidance while detailing progress on its five-year transformation and addressing regulatory challenges. Strong FY25 financial results and a robust market pipeline underpin the company’s outlook.

Wellard Limited has formally requested to delist from the ASX following the sale of its final revenue-generating vessel, aiming to reduce costs and return excess cash to shareholders. The move awaits shareholder approval at the upcoming AGM.

ASX Limited has updated its dividend notification to include the New Zealand dollar exchange rate, NZD equivalent dividend amount, and the dividend reinvestment plan price for the first half of FY25.

The ASX has suspended the securities of 36 companies for failing to pay their annual listing fees by the August 21 deadline, with a looming delisting threat if fees remain unpaid by August 28.

Gladiator Resources has inked a strategic agreement with Apex USA Resources to explore and develop rare earth element tenements in the United States, marking a significant diversification from its Tanzanian uranium projects.

ASX Limited reported a solid FY25 financial performance with a 7.5% rise in underlying net profit and a higher fully franked dividend, while advancing its CHESS replacement project amid ongoing regulatory scrutiny.